Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
EUSA Pharma
Pharma
Recordati to acquire EUSA Pharma for €750m ($845 million)
Recordati has agreed on a price for EUSA Pharma. The Milan-based firm will pay $845 million for EUSA’s portfolio of rare cancer drugs.
Kevin Dunleavy
Dec 3, 2021 11:10am
Sanofi, Regeneron cut severe patients in Kevzara COVID-19 study
Apr 27, 2020 10:45am
EUSA Pharma opens COVID-19 trial for IL-6 inhibitor Sylvant
Mar 18, 2020 9:43am
